Skip to main content

Basel among the most future-oriented cities in Europe

fDi Intelligence - small european cities of the future 2022/23
| News

Basel among the most future-oriented cities in Europe


fDi Intelligence has investigated the most important tech cities across Europe. Basel secured top spot for cities up to 350'000 people. In terms of foreign direct investment strategies, the Basel Area was ranked in second place in regions category up to 1,5 Mio people.

fDi Intelligence - small european cities of the future 2022/23
Copyright. Basel Tourism

The competence center for foreign direct investment of the Financial Times, fDi Intelligence, has once again compared Europe’s future-oriented tech cities. In the ranking, Basel achieved the top position for European tech cities of the future, for cities with populations of between 100,000 and 350,000 people.

The city owes its top ranking above all to its economic potential. In the specific ranking for this aspect, Basel took second place across Europe. The city’s significant human capital and good quality of life saw it also ranked in fourth place for this category.

The ranking also highlighted that Basel is home to major pharma giants such as RocheNovartis, and Roivant Sciences. However, the city also attracts investments in the area of professional services. Hence service providers were responsible for more than a quarter of new investments in Basel in the period between October 2016 and September 2021. In addition, the city’s key strategic position at the border between Switzerland, Germany, and France was highlighted.

fDi small european cities of the future 2022/23
European Cities and Regions of the Future 2022/23 (fDi Intelligence)

Furthermore, fDi Intelligence produced a ranking specifically for European regions. Here, the focus was primarily on strategies for attracting foreign direct investment. In the category of small regions, the Basel Area claimed second place in the overall European ranking.

Award Ceremony in Cannes

The fDi Intelligence awards remain valid for a period of two years. The award ceremony is set to take place in Cannes, France, on March 15.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Forty51 Ventures invests to found Mysthera Therapeutics

Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided...
Read More

Spexis receives capital commitment of 2.5 million US dollars

Investors have made an additional capital commitment to Spexis AG, based in the Basel Area. With an extra 2.5 million...
Read More

Do you have a question? We'd like to hear from you.